Enhabit Home Health & Hospice (NYSE: EHAB) is a leading provider of home-based patient care services. The company was recently acquired by Kinderhook Industries, a private investment firm, signaling a new strategic direction. Following the acquisition, Dale Clift was appointed as the new president and CEO, bringing extensive leadership experience in the home health sector, as highlighted by Business Wire.
On May 20, 2026, EHAB reported its quarterly financial results. The company announced earnings of $0.13 per share for the quarter. This figure successfully surpassed the analyst consensus estimate, which was projected to be $0.12 per share, indicating a slight outperformance in profitability.
While earnings were positive, the company's revenue came in just below expectations. EHAB reported quarterly revenue of $264.8 million. This amount fell slightly short of the analyst consensus estimate of $266.66 million, showing a minor gap between expected and actual sales for the period.
Despite the mixed results, there is growing optimism about the company's prospects. As highlighted by Zacks Investment Research, EHAB's stock was upgraded to a Zacks Rank #2 (Buy). This upgrade is often based on positive trends in earnings estimate revisions, suggesting analysts are becoming more confident in the company's future performance and investment outlook.
